𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, double-blind comparison of risedronate and etidronate in the treatment of paget’s disease of bone

✍ Scribed by Paul D Miller; Jacques P Brown; Ethel S Siris; Mohammad S Hoseyni; Douglas W Axelrod; Pirow J Bekker

Book ID
117016349
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
122 KB
Volume
106
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of etidronate (ehdp) in paget's dise
Use of etidronate (ehdp) in paget's disease of bone
✍ C. Conrad Johnston Jr; M. R. A. Khairi; P. J. Meunier 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 1 views

## Abstract Etidronate used in recommended doses (usually 5 mg/kg/day for 6 months) produces symptomatic improvement in approximately 60% of patients. The serum alkaline phosphatase and urinary hydroxyproline are reduced to about 50% of initial values. A sustained remission occurs in many patients